Authors:
NACCACHE P
MUNCK JN
BRAULT P
DECAUDIN D
KOSCIELNY S
BOSQ J
BENNACEUR AL
CARDE P
PICO JL
ULUZAKARYA A
BOURHIS JH
GILLES E
HAYAT M
Citation: P. Naccache et al., LONG-TERM FOLLOW-UP OF A SUPER CHVMP-VB REGIMEN IN PATIENTS WITH HIGH-RISK NON-HODGKINS-LYMPHOMA OF AGGRESSIVE HISTOLOGY, Blood, 88(10), 1996, pp. 1796-1796
Authors:
BRAULT P
GILLES E
RIBRAG V
BOURHIS JH
MUNCK JN
PICO JL
HAYAT M
Citation: P. Brault et al., SALVAGE TREATMENT OF RELAPSING LYMPHOMAS WITH A NON-MYELOTOXIC CHEMOTHERAPY COMBINING CISPLATINUM, BLEOMYCIN, METHYL GAG, AND PREDNISOLONE, Bulletin du cancer, 82(12), 1995, pp. 1032-1037
Authors:
DAYAN A
DOMENECH J
ROINGEARD F
FLORENCE S
GEORGET MT
GILLES E
COLOMBAT P
BINET C
Citation: A. Dayan et al., IN-VITRO ACTIVITY OF ALL-TRANS-RETINOIC ACID (ATRA) ALONE AND IN COMBINATION WITH G-CSF, STEM-CELL FACTOR (SCF), 1,25-DIHYDROXYVITAMIN-D3 (VITD3) OR INTERFERON-ALPHA (IFN-ALPHA) ON NORMAL BONE-MARROW CELLS, Blood, 84(10), 1994, pp. 10000565-10000565
Authors:
REIFFERS J
FABERES C
BOIRON M
MARIT G
FOURES C
FERRER AM
CONYMAKHOUL P
PUNTOUS M
GILLES E
BERNARD P
VEZON G
BROUSTET A
Citation: J. Reiffers et al., PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANTATION IN 118 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES - ANALYSIS OF FACTORS AFFECTING THERATE OF ENGRAFTMENT, Blood, 82(10), 1993, pp. 10000166-10000166